IXICO plc
PHYOF · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13.3% | -13.5% | -22.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 48.7% | 47% | 49.1% | 55.2% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -30.9% | -33.7% | -10.6% | 8.7% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -25.3% | -34.7% | -17.7% | 11.9% |
| EPS Diluted | -0.019 | -0.041 | -0.024 | 0.02 |
| % Growth | 55.3% | -69.7% | -220.2% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |